MedTrace Logo

Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer

NCT06879197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1187

Last updated 2025-03-17

No results posted yet for this study

Summary

We evaluated all related clinical and pathologic data of patients with Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy, including the pathologic regression grading, and other histopathologic characteristics. Finally, the present study was aimed at (1) clarifying the clinical significance of the Major Pathologic Regression for Locally Advanced Rectal Cancer following Locally Advanced Rectal Cancer and (2) comparing different Neoadjuvant Chemoradiotherapy treatments of this uncommon disease through conducting a large, multi-center cohort study.

Conditions

  • Rectal Neoplasms
  • Chemotherapy Effect

Sponsors & Collaborators

  • Yanhong Deng

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2022-12-30
Completion
2023-03-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06879197 on ClinicalTrials.gov